"Cholesterol Paradox" in Atrial Fibrillation

被引：25
|
作者：
Suzuki, Shinya [1 ]
机构：
[1] Cardiovasc Inst, Dept Cardiovasc Med, Minato Ku, Tokyo 1060031, Japan
来源：
CIRCULATION JOURNAL | 2011年 / 75卷 / 12期
关键词：
C-REACTIVE PROTEIN; RISK-FACTORS; JAPAN; ASSOCIATION; POPULATION;
D O I：
10.1253/circj.CJ-11-1134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2749 / 2750
页数：2
相关论文
共 50 条
  • [41] LDL Cholesterol and Ischemic Stroke in Patients with Nonvalvular Atrial Fibrillation
    Oni, Ebenezer
    Ogunmoroti, Oluseye
    Allen, Norrina
    A-Mallah, Mouaz H.
    Blankstein, Ron
    Martin, Seth S.
    Zeb, Irfan
    Cushman, Mary
    Joshi, Parag H.
    Budoff, Matthew J.
    Blaha, Michael J.
    Blumenthal, Roger S.
    Veledar, Emir
    Nasir, Khurram
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (04): : 519 - 525
  • [42] The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation
    Minami-Takano, Asuka
    Iwata, Hiroshi
    Miyosawa, Katsutoshi
    Shiozawa, Tomoyuki
    Hayashi, Hidemori
    Funamizu, Takehiro
    Ishii, Kai
    Nozaki, Yui
    Tabuchi, Haruna
    Sekita, Gaku
    Shimada, Kazunori
    Sumiyoshi, Masataka
    Nakazato, Yuji
    Daida, Hiroyuki
    Minamino, Tohru
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [43] The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation
    Asuka Minami-Takano
    Hiroshi Iwata
    Katsutoshi Miyosawa
    Tomoyuki Shiozawa
    Hidemori Hayashi
    Takehiro Funamizu
    Kai Ishii
    Yui Nozaki
    Haruna Tabuchi
    Gaku Sekita
    Kazunori Shimada
    Masataka Sumiyoshi
    Yuji Nakazato
    Hiroyuki Daida
    Tohru Minamino
    Scientific Reports, 11
  • [44] The Atrial Fibrillation Ethnic Paradox: Insights From National Inpatient Sample Database
    Kowlgi, N. Gurukripa
    Gunda, Sampath
    Padala, Santosh
    Ellenbogen, Kenneth A.
    CIRCULATION, 2017, 136
  • [45] Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant Drugs
    Marco Proietti
    Giuseppe Boriani
    American Journal of Cardiovascular Drugs, 2020, 20 : 125 - 137
  • [46] The Influence of Body Mass Index on Outcomes in Patients With Atrial Fibrillation: The Obesity Paradox
    Wang, Juan
    Shao, Xing-hui
    Zhang, Han
    Tian, Li
    Huang, Bi
    Yang, Yan-min
    Zhu, Jun
    CIRCULATION, 2013, 128 (22)
  • [47] Healthy lifestyle and atrial fibrillation recurrence after pulmonary vein isolation - a paradox?
    Krisai, P.
    Knecht, S.
    Badertscher, P.
    Vollmin, G.
    Spies, F.
    Schar, B.
    Osswald, S.
    Sticherling, C.
    Kuhne, M.
    SWISS MEDICAL WEEKLY, 2022, 152 : 44S - 45S
  • [48] Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship with Oral Anticoagulant Drugs
    Proietti, Marco
    Boriani, Giuseppe
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (02) : 125 - 137
  • [49] Warfarin for nonvalvular atrial fibrillation in primary care - another example of the age paradox?
    Burton, CD
    Hamilton, KES
    Isles, CG
    Norrie, J
    JOURNAL OF CARDIOVASCULAR RISK, 2001, 8 (05): : 307 - 309
  • [50] The "obesity paradox" in patients with atrial fibrillation: Insights from the Gulf SAFE registry
    Li, Yan-Guang
    Xie, Peng-Xin
    Alsheikh-Ali, Alawi A.
    AlMahmeed, Wael
    Sulaiman, Kadhim
    Asaad, Nidal
    Liu, Shu-Wang
    Zubaid, Mohammad
    Lip, Gregory Y. H.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345